GlassScriptPhysician profile
Trevor Payne
NPI 1467887877
$6,592.28
in general payments reported to CMS, 2019-2025
44 companies · $1,751 in 2025
The $1,751 reported for 2025 was more than what 81% of Foot & Ankle Surgery providers received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $537 · 2020: $551 · 2021: $918 · 2022: $966 · 2023: $1,390 · 2024: $479 · 2025: $1,751.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,055 · Debt Forgiveness: $1,200 · Travel and Lodging: $365.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,055.26 |
| Debt Forgiveness | $1,200.00 |
| Travel and Lodging | $365.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Convatec INC. | $1,336.94 | 2023-2025 | |
| Treace Medical Concepts, INC. | $1,042.64 | 2020-2025 | |
| Stryker Corporation | $770.23 | 2021-2025 | Infinity, Prophecy, Citrefix |
| Smith+Nephew, INC. | $431.62 | 2019-2025 | Collagenase Santyl, Vlp Foot, Grafix Pl |
| Horizon Therapeutics Plc | $358.93 | 2019-2022 | |
| Bioventus LLC | $292.01 | 2019-2025 | Exogen Ultrasound Bone Healing System, Exogen Ultrasound Bone Healing System |
| Depuy Synthes Sales INC. | $284.46 | 2021-2025 | Na, Motoband, N/A |
| Melinta Therapeutics, LLC | $222.44 | 2021-2022 | |
| Team 1, LLC | $203.81 | 2023 | |
| Crossroads Extremity Systems, LLC | $148.49 | 2020-2021 | |
| Organogenesis INC. | $139.99 | 2020-2023 | Puraply |
| Ibsa Pharma INC. | $137.12 | 2021-2024 | Tirosint, Licart, Flector |
| Polarityte, INC. | $116.48 | 2019 | |
| Nevro Corp. | $108.79 | 2021-2022 | |
| Comsort, INC | $100.00 | 2019 |
Show all 44 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Dynasplint Systems INC. | $89.57 | 2021 | |
| Extremity Medical | $70.33 | 2019 | |
| Geistlich Pharma, North America, INC. | $65.05 | 2022 | |
| Fidia Pharma USA INC. | $64.76 | 2023 | Triluron, Hymovis |
| Abbvie INC. | $64.49 | 2021-2023 | |
| Nabriva Therapeutics, Plc | $60.79 | 2021-2022 | |
| In2bones USA, LLC | $53.16 | 2019-2022 | |
| Paratek Pharmaceuticals, INC. | $53.08 | 2022-2024 | Nuzyra |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $32.63 | 2022-2023 | Jublia |
| Abbott Laboratories | $29.74 | 2023-2025 | Proclaim |
| Zyla Life Sciences, INC. | $24.08 | 2019-2020 | |
| Averitas Pharma INC. | $23.37 | 2023 | Qutenza |
| Solventum Corporation | $22.68 | 2025 | Activ.A.C., Snap, Promogran Prisma |
| Kci USA, INC. | $20.92 | 2020 | |
| Kuros Biosciences USA, INC | $19.96 | 2022 | |
| Trilliant Surgical LLC. | $19.18 | 2019 | |
| Pacira Pharmaceuticals Incorporated | $17.98 | 2019 | |
| Glenmark Therapeutics INC. | $17.00 | 2019 | |
| Lemaitre Vascular, INC. | $16.22 | 2025 | Restoreflow |
| Allergan, INC. | $16.16 | 2020 | |
| Becton, Dickinson and Company | $16.11 | 2024 | Venclose Maven Catheter |
| Pfizer INC. | $15.87 | 2020 | |
| Arthrosurface Incorporated | $14.02 | 2019 | |
| Ethicon US, LLC | $13.86 | 2023 | Vistaseal, Stratafix |
| Ermi LLC | $13.38 | 2019 | |
| Medtronic, INC. | $12.81 | 2023 | Intellis Adaptivestim |
| Assertio Therapeutics, INC. | $11.42 | 2020 | |
| Kerecis Limited | $10.80 | 2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide |
| Merck Sharp & Dohme LLC | $8.91 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Trevor Payne listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
The CSV has this whole record: totals, yearly figures, every listed company, payment types, and product associations.
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.